van Denderen B, Pêche H, Gagne K, Usal C, Cuturi M C, Soulillou J P
INSERM Unite 437 Immunointervention dans les Allo et Xenotransplantations and Institut de Transplantation Et de Recherche en Transplantation, CHU-HOTEL DIEU, Nantes, France.
Eur J Immunol. 2001 May;31(5):1333-9. doi: 10.1002/1521-4141(200105)31:5<1333::AID-IMMU1333>3.0.CO;2-1.
Pre-graft priming of heart allograft recipients with donor strain blood induces tolerance in 100% of adult rats in the congenic LEW.1W to LEW.1A combination. This tolerant state is specific for donor MHC antigens as third-party blood transfusions fail to induce tolerance, and third-party skin grafts are promptly rejected by tolerant graft recipients. In this study we have characterized the immunodominant donor (RT1u) class I and II allogenic peptides which elicit an in vitro proliferative response to splenocytes from recipients (RT1a) undergoing acute rejection or tolerant to a LEW.1A cardiac allograft. Paradoxically, splenocytes from tolerant animals responded more vigorously to a broader set of donor peptides than splenocytes from rejecting animals. In addition, several of these peptides were observed to be stimulatory only for tolerant splenocytes. These findings suggest that regulatory cells may be involved in tolerance induction or maintenance and are selected by specific motifs, which could be utilized for manipulating the immune system of graft recipients.
用供体品系血液对心脏同种异体移植受体进行移植前预处理,可使同基因LEW.1W至LEW.1A组合中的100%成年大鼠产生耐受性。这种耐受状态对供体MHC抗原具有特异性,因为第三方输血不能诱导耐受性,而第三方皮肤移植会被耐受的移植受体迅速排斥。在本研究中,我们鉴定了免疫显性供体(RT1u)I类和II类同种异体肽,这些肽可引发来自经历急性排斥或对LEW.1A心脏同种异体移植耐受的受体(RT1a)脾细胞的体外增殖反应。矛盾的是,与来自排斥动物的脾细胞相比,来自耐受动物的脾细胞对更广泛的供体肽反应更强烈。此外,观察到其中几种肽仅对耐受脾细胞具有刺激作用。这些发现表明,调节性细胞可能参与耐受性的诱导或维持,并由特定基序选择,这可用于操纵移植受体的免疫系统。